Kirsch Arthur S 4
4 · Atea Pharmaceuticals, Inc. · Filed Feb 24, 2025
Insider Transaction Report
Form 4
Kirsch Arthur S
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-20+164,800→ 164,800 totalExercise: $3.14Exp: 2035-02-19→ Common Stock (164,800 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in thirty-six (36) equal monthly installments following February 20, 2025 such that the option is fully vested on February 20, 2028.